ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.92078
-0.37%
Brent Oil
83.61
0.58%
Bitcoin
64,086.34
0.14%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
06/05/202406:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:BAMBrookfield Asset Management Ltd
06/05/202406:00Business WireStoke Therapeutics Reports First Quarter Financial Results and Provides Business UpdatesNASDAQ:STOKStoke Therapeutics Inc
06/05/202406:00Business WireOrigin Materials Introduces World’s First CSD (Carbonated Soft Drink) PET Cap, the Lightest of its Kind Ever Produced CommerciallyNASDAQ:ORGNOrigin Materials Inc
06/05/202406:00Business WireBirdville Independent School District Announces Partnership with Varsity Tutors for Schools to Provide Live and On-Demand Learning Resources for All StudentsNYSE:NRDYNerdy Inc
06/05/202406:00Business WireMY DR NOW Opens New Primary Care Clinic in Peoria, Arizona
06/05/202406:00Business WireXeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta BionicsNASDAQ:XERSXeris Biopharma Holdings Inc
06/05/202406:00Business WireTicura Launches First-of-its-Kind Global Threat Intelligence Curation Solution for Managed Security Solution Providers (MSSPs) and Global Enterprises
06/05/202406:00GlobeNewswire Inc.Signify share repurchase periodic updateTG:G14Signify NV
06/05/202406:00GlobeNewswire Inc.Boussard & Gavaudan Investment Management LLP: Form 8.3 -
06/05/202406:00GlobeNewswire Inc.Lerøy Seafood Group ASA: Notice of General Shareholders' MeetingTG:Z1LLeroy Seafood Group
06/05/202406:00Business WireWisdomTree Sends Letter to Stockholders Urging Full Support of the Current Board to Continue the Company’s Strong MomentumNYSE:WTWisdomTree Inc
06/05/202406:00Business WireAtlas Energy Solutions Announces Appointment of Blake McCarthy as Chief Financial OfficerNYSE:AESINew Atlas Holdco Inc
06/05/202406:00Business WireCan-Fite Received Notice of Allowance from the European Patent Office for the Treatment of Erectile Dysfunction with CF602AMEX:CANFCan Fite BioPharma Ltd
06/05/202406:00Business WireMaiden Holdings, Ltd. Announces Renewal Rights Transaction for International Primary BusinessNASDAQ:MHLDMaiden Holdings Ltd
06/05/202406:00Business WireCheckmarx Forges Secure Path to Accelerate AI Adoption in Application Security and Developer Workflows
06/05/202406:00Business WireAnetac Emerges from Stealth to Empower Enterprises with a Streaming Identity Solution Revolutionizing Service Account Security, Raises $16M in Funding
06/05/202406:00Business WireOtsuka America, Inc’s. Data and Technology Company will Support Rejoyn™ Commercialization & Personalized Patient Engagement
06/05/202406:00Business Wirebluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene TherapyNASDAQ:BLUEbluebird bio Inc
06/05/202406:00Business WireVirgin Galactic Begins Operations at Delta Spaceship Ground Testing FacilityNYSE:SPCEVirgin Galactic Holdings Inc
06/05/202405:59Business WireEuropean Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...NYSE:BMYBristol Myers Squibb Co
06/05/202405:59Business WireU.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)NYSE:BMYBristol Myers Squibb Co
06/05/202405:57Edgar (US Regulatory)Form 8-K - Current reportNYSE:SOJEThe Southern Company
06/05/202405:55PR Newswire (US)TreeHouse Foods, Inc. Reports First Quarter 2024 ResultsNYSE:THSTreehouse Foods Inc
06/05/202405:55PR Newswire (US)GLOBE LIFE INC. DECLARES DIVIDENDNYSE:GLGlobe Life Inc
06/05/202405:55PR Newswire (US)Southern Company announces offering of $1.1 billion in aggregate principal amount of Convertible Senior Notes due June 15, 2027NYSE:SOSouthern Co
06/05/202405:55PR Newswire (Canada)/R E P R I S E -- Invitation aux médias - Vernissage des œuvres d'art de Nicolas Baier et Ludovic Boney à l'édifice Hélène-Desmarais de HEC Montréal/
06/05/202405:51Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
06/05/202405:50PR Newswire (US)KEB America Showcases Servo Pump Control Solutions at NPE 2024
06/05/202405:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:YUMCYum China Holdings Inc
06/05/202405:45GlobeNewswire Inc.BioNTech veröffentlicht Ergebnisse für das erste Quartal 2024 sowie Informationen zur GeschäftsentwicklungXE:22UABioNTech SE

Su Consulta Reciente

NASDAQ
AMZN
Amazon.com
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
NYSE
DIS
Walt Disney
AMEX
XLF
Financial Select Sector
FX
USDMXN
US Dollar vs MXN
NASDAQ
AAPL
Apple
COIN
SOLUSD
Solana
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MRK
Merck
NYSE
XOM
Exxon Mobil
USOTC
ADDYY
Adidas (QX)
CCOM
US30
US 30
AMEX
SPY
SPDR S&P 500
CCOM
OILBRENT
Brent Oil
COIN
ETHUSD
Ethereum
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados